Human medicines European public assessment report EPAR Zoledronic Acid Accord zoledronic acid HypercalcemiaFractures BoneCancer Date of authorisation 16012014 Revision 5 Status Authorised

Human medicines European public assessment report (EPAR): Zoledronic Acid Accord, zoledronic acid, Hypercalcemia,Fractures, Bone,Cancer, Date of authorisation: 16/01/2014, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Zoledronic Acid Accord, zoledronic acid, Hypercalcemia,Fractures, Bone,Cancer, Date of authorisation: 16/01/2014, Revision: 5, Status: Authorised

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Zoledronic Acid Accord, zoledronic acid, Hypercalcemia,Fractures, Bone,Cancer, Date of authorisation: 16/01/2014, Revision: 5, Status: Authorised"